Caveolin and cavin family members: Dual roles in cancer

Biochimie

Volumn 107, Issue PB, 2014, Pages 188-202

  Gupta, Reshu ^a   Toufaily, Chirine ^a   Annabi, Borhane ^a  

^a UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

Author keywords

Cancer; Caveolin; Cavin

Indexed keywords

CAVEOLIN 1; CAVEOLIN 2; CAVEOLIN 3; CAVIN; CAVIN 1; CAVIN 2; CAVIN 3; CAVIN 4; MEMBRANE PROTEIN; TUMOR PROMOTER; UNCLASSIFIED DRUG; CARRIER PROTEIN; CAVEOLIN; PRKCDBP PROTEIN, HUMAN; PTRF PROTEIN, HUMAN; RNA BINDING PROTEIN; SDPR PROTEIN, HUMAN; SIGNAL PEPTIDE; TUMOR SUPPRESSOR PROTEIN;

ANCHORAGE INDEPENDENT GROWTH; APOPTOSIS; CANCER CELL; CANCER DIAGNOSIS; CANCER INHIBITION; CANCER STAGING; CARBOXY TERMINAL SEQUENCE; CARCINOGENESIS; CELL DIFFERENTIATION; CELL FUNCTION; CELL MEMBRANE; CELL TRANSFORMATION; GENE FREQUENCY; GENE PRODUCT; GOLGI COMPLEX; HUMAN; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; NONHUMAN; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSPORT VESICLE; TUMOR INVASION; TUMOR SUPPRESSOR GENE; CAVEOLA; METABOLISM; NEOPLASM; PATHOLOGY; PHYSIOLOGY;

APOPTOSIS; CARRIER PROTEINS; CAVEOLAE; CAVEOLINS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NEOPLASMS; RNA-BINDING PROTEINS; TUMOR SUPPRESSOR PROTEINS;

EID: 84915781234     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2014.09.010     Document Type: Review

References (255)

1. G.E. Palade Fine structure of blood capillaries J. Appl. Phys. 24 1953 1424 1436
2. T. Richter, M. Floetenmeyer, C. Ferguson, J. Galea, J. Goh, M.R. Lindsay, G.P. Morgan, B.J. Marsh, and R.G. Parton High-resolution 3D quantitative analysis of caveolar ultrastructure and caveola-cytoskeleton interactions Traffic 9 2008 893 909
3. W. Schlormann, F. Steiniger, W. Richter, R. Kaufmann, G. Hause, C. Lemke, and M. Westermann The shape of caveolae is omega-like after glutaraldehyde fixation and cup-like after cryofixation Histochem Cell. Biol. 133 2010 223 228
4. L. Pelkmans, and M. Zerial Kinase-regulated quantal assemblies and kiss-andrun recycling of caveolae Nature 436 2005 128 133
5. M.M. Hill, M. Bastiani, R. Luetterforst, M. Kirkham, A. Kirkham, S.J. Nixon, P. Walser, D. Abankwa, V.M. Oorschot, S. Martin, J.F. Hancock, and R.G. Parton PTRF-Cavin, a conserved cytoplasmic protein required for caveola formation and function Cell 132 2008 113 124
6. R. Chadda, and S. Mayor PTRF triggers a cave in Cell 132 2008 23 24
7. R. Nabi Cavin fever: regulating caveolae Nat. Cell. Biol. 11 2009 789 791
8. N. McLaughlin, B. Annabi, M. Bouzeghrane, A. Temme, J.P. Bahary, R. Moumdjian, and R. Béliveau The Survivin-mediated radioresistant phenotype of glioblastomas is regulated by RhoA and inhibited by the green tea polyphenol (-)-epigallocatechin-3-gallate Brain Res. 1071 1 2006 1 9
9. B. Annabi, Y.T. Lee, C. Martel, A. Pilorget, J.P. Bahary, and R. Béliveau Radiation induced-tubulogenesis in endothelial cells is antagonized by the antiangiogenic properties of green tea polyphenol (-) epigallocatechin-3-gallate Cancer Biol. Ther. 2 6 2003 642 649
10. C.S. Huang, J. Zhou, A.K. Feng, C.C. Lynch, J. Klumperman, S.J. DeArmond, and W.C. Mobley Nerve growth factor signaling in caveolae-like domains at the plasma membrane J. Biol. Chem. 274 1999 36707 36714
11. M. Isshiki, and R.G. Anderson Calcium signal transduction from caveolae Cell. Calcium 26 1999 201 208
12. S. Roy, R. Luetterforst, A. Harding, A. Apolloni, M. Etheridge, E. Stang, B. Rolls, J.F. Hancock, and R.G. Parton Dominant-negative caveolin inhibits H-Ras function by disrupting cholesterol-rich plasma membrane domains Nat. Cell. Biol. 1 1999 98 105
13. E.J. Smart, G.A. Graf, M.A. McNiven, W.C. Sessa, J.A. Engelman, P.E. Scherer, T. Okamoto, and M.P. Lisanti Caveolins, liquid-ordered domains, and signal transduction Mol. Cell. Biol. 19 1999 7289 7304
14. M. Bucci, J.P. Gratton, R.D. Rudic, L. Acevedo, F. Roviezzo, G. Crino, and W.C. Sessa In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis, and reduces inflammation Nat. Med. 6 2000 1362 1367
15. C. Dessy, R.A. Kelly, J.L. Balligand, and O. Feron Dynamin mediates caveolar sequestration of muscarinic cholinergic receptors, and alteration in NO signaling EMBO J. 19 2000 4272 4280
16. B. Ranzani, A. Schlegel, and M.P. Lisanti Caveolin proteins in signaling, oncogenic transformation, and muscular dystrophy J. Cell. Sci. 113 2000 2103 2109
17. M. Stahlhut, K. Sandvig, and B. Van Deurs Caveolae: uniform structures with multiple functions in signaling, cell growth, and cancer Exp. Cell. Res. 261 2000 111 118
18. K.K. Wary, F. Mainiero, S.J. Isakoff, E.E. Marcantonio, and F.G. Giancotti The adaptor protein Shc couples a class of integrins to the control of cell cycle progression Cell 87 1996 733 743
19. Y. Wei, X. Yanf, Q. Liu, J.A. Wilkins, and H.A. Chapman A role for caveolin and the urokinase receptor in integrin-mediated adhesion and signaling J. Cell. Biol. 144 1999 1285 1294
20. M. Shatz, and M. Liscovitch Caveolin-1: a tumor-promoting role in human cancer Int. J. Radiat. Biol. 84 2008 177 189
21. G. Yang, L.D. Truong, T.L. Timme, C. Ren, T.M. Wheeler, S.H. Park, Y. Nasu, C.H. Bangma, M.W. Kattan, P.T. Scardino, and T.C. Thompson Elevated expression of caveolin is associated with prostate and breast cancer Clin. Cancer Res. 4 1998 1873 1880
22. G. Yang, L.D. Truong, T.M. Wheeler, and T.C. Thompson Caveolin-1 expression in clinically confined human prostate cancer: a novel prognostic marker Cancer Res. 59 1999 5719 5723
23. C.C. Ho, P.H. Huang, H.Y. Huang, Y.H. Chen, P.C. Yang, and S.M. Hsu Up-regulated caveolin-1 accentuates the metastasis capability of lung adenocarcinoma by inducing filopodia formation Am. J. Pathol. 161 2002 1647 1656
24. H.J. Joo, D.K. Oh, Y.S. Kim, K.B. Lee, and S.J. Kim Increased expression of caveolin-1 and microvessel density correlates with metastasis and poor prognosis in clear cell renal cell carcinoma BJU Int. 93 2004 291 296
25. K. Kato, Y. Hida, M. Miyamoto, H. Hashida, T. Shinohara, T. Itoh, S. Okushiba, S. Kondo, and H. Katoh Overexpression of caveolin-1 in esophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage Cancer 94 2002 929 933
26. T.M. Williams, and M.P. Lisanti The caveolin proteins Genome Biol. 4 2004 214 221
27. T. Okamoto, A. Schlegel, P.E. Scherer, and M.P. Lisanti Caveolins, a family of scaffolding proteins for organizing 'preassembled signaling complexes' at the plasma membrane J. Biol. Chem. 273 1998 5419 5422
28. A. Schlegel, and M.P. Lisanti A molecular dissection of caveolin-1 membrane attachment and oligomerization. Two separate regions of the caveolin-1 carboxy-terminal domain mediate membrane binding and oligomer/oligomer interactions in vivo J. Biol. Chem. 275 2000 21605 21617
29. T.V. Kurzchalia, P. Dupree, R.G. Parton, R. Kellner, H. Virta, M. Lehnert, and K. Simons VIP 21, A 21-kDa membrane protein is an integral component of trans-Golgi-network-derived transport vesicles J. Cell. Biol. 118 1992 1003 1014
30. J.R. Glenney, and D. Soppet Jr. Sequence and expression of caveolin, a protein component of caveolae plasma membrane domains phosphorylated on tyrosine in Rous sarcoma virus-transformed fibroblasts Proc. Natl. Acad. Sci. U S A 89 1992 10517 10521
31. P. Liu, M. Rudick, and R.G. Anderson Multiple functions of caveolin-1 J. Biol. Chem. 277 2002 41295 41298
32. W.P. Li, P. Liu, B.K. Pilcher, and R.G. Anderson Cell-specific targeting of caveolin-1 to caveolae, secretory vesicles, cytoplasm or mitochondria J. Cell. Sci. 114 2001 1397 1408
33. B. Razani, S.E. Woodman, and M.P. Lisanti Caveolae: from cell biology to animal physiology Pharmacol. Rev. 54 2002 431 467
34. S. Li, J. Couet, and M.P. Lisanti Src tyrosine kinases, Galpha subunits, and H-Ras share a common membrane anchored scaffolding protein, caveolin. Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases J. Biol. Chem. 271 1996 29182 29190
35. N. Nohata, T. Hanazawa, N. Kikkawa, M. Mutallip, L. Fujimura, H. Yoshino, K. Kawakami, T. Chiyomaru, H. Enokida, M. Nakagawa, Y. Okamoto, and N. Seki Caveolin-1 mediates tumor cell migration and invasion and its regulation by miR-133a in head and neck squamous cell carcinoma Int. J. Oncol. 38 2011 209 217
36. B. Annabi, M. Lachambre, N. Bousquet-Gagnon, M. Pagé, D. Gingras, and R. Béliveau Localization of membrane-type 1 matrix metalloproteinase in caveolae membrane domains Biochem. J. 353 Pt 3 2001 547 553
37. B. Annabi, S. Thibeault, R. Moumdjian, and R. Béliveau Hyaluronan cell surface binding is induced by type I collagen and regulated by caveolae in glioma cells J. Biol. Chem. 279 21 2004 21888 21896
38. H. Kogo, T. Aiba, and T. Fujimoto Cell type-specific occurrence of caveolin-1alpha and - 1beta in the lung caused by expression of distinct mRNAs J. Biol. Chem. 279 2004 25574 25581
39. H. Kogo, and T. Fujimoto Caveolin-1 isoforms are encoded by distinct mRNAs. Identification of mouse caveolin-1 mRNA variants caused by alternative transcription initiation and splicing FEBS Lett. 465 2000 119 123
40. P.E. Scherer, Z. Tang, M. Chun, M. Sargiacomo, H.F. Lodish, and M.P. Lisanti Caveolin isoforms differ in their N-terminal protein sequence and subcellular distribution. Identification and epitope mapping of an isoform-specific monoclonal antibody probe J. Biol. Chem. 270 1995 16395 16401
41. G. Sowa, M. Pypaert, D. Fulton, and W.C. Sessa The phosphorylation of caveolin-2 on serines 23 and 36 modulates caveolin-1-dependent caveolae formation Proc. Natl. Acad. Sci. U S A. 100 11 2003 6511 6516
42. J.R. Glenney, and L. Zokas Novel tyrosine kinase substrates from Rous sarcoma virus-transformed cells are present in the membrane skeleton J. Cell. Biol. 108 1989 2401 2408
43. S. Li, R. Seitz, and M.P. Lisanti Phosphorylation of caveolin by Src tyrosine kinases: the α-isoform of caveolin is selectively phosphorylated by v-Src in vivo J. Biol. Chem. 271 1996 3863 3868
44. A.R. Sanguinetti, and C.C. Mastick c-Abl is required for oxidative stress-induced phosphorylation of caveolin-1 on tyrosine 14 Cell. Signal. 15 2003 289 298
45. A.R. Sanguinetti, H. Cao, and C. Corley Mastick Fyn is required for oxidative- and hyperosmotic-stress-induced tyrosine phosphorylation of caveolin-1 Biochem. J. 376 2003 159 168
46. A. Schlegel, P. Arvan, and M.P. Lisanti Caveolin-1 binding to endoplasmic reticulum membranes and entry into the regulated secretory pathway are regulated by serine phosphorylation. Protein sorting at the level of the endoplasmic reticulum J. Biol. Chem. 276 2001 4398 4408
47. S. Monier, D.J. Dietzen, W.R. Hastings, D.M. Lublin, and T.V. Kurzchalia Oligomerization of VIP21-caveolin in vitro is stabilized by long chain fatty acylation or cholesterol FEBS Lett. 388 1996 143 149
48. D.J. Dietzen, W.R. Hastings, and D.M. Lublin Caveolin is palmitoylated on multiple cysteine residues. Palmitoylation is not necessary for localization of caveolin to caveolae J. Biol. Chem. 270 1995 6838 6842
49. D. Volonte, F. Galbiati, R.G. Pestell, and M.P. Lisanti Cellular stress induces the tyrosine phosphorylation of caveolin-1 (Tyr(14)) via activation of p38 mitogen-activated protein kinase and c-Src kinase. Evidence for caveolae, the actin cytoskeleton, and focal adhesions as mechanical sensors of osmotic stress J. Biol. Chem. 276 2001 8094 8103
50. B. Van Deurs, K. Roepstorff, A.M. Hommelgaard, and K. Sandvig Caveolae: anchored, multifunctional platforms in the lipid ocean Trends Cell. Biol. 13 2003 92 100
51. F. Sotgia, J.K. Lee, K. Das, M. Bedford, T.C. Petrucci, P. Macioce, M. Sargiacomo, F.D. Bricarelli, C. Minetti, M. Sudol, and M.P. Lisanti Caveolin-3 directly interacts with the carboxy-terminal tail of beta-dystroglycan. Identification of a central WW-like domain within caveolin family members J. Biol. Chem. 275 2000 38048 38058
52. F. Bender, M. Montoya, V. Monardes, L. Leyton, and A.F. Quest Caveolae and caveolae like membrane domains in cellular signaling and disease: identification of downstream targets for the tumor suppressor protein caveolin-1 Biol. Res. 35 2002 151 167
53. T. Machleidt, W.P. Li, P. Liu, and R.G. Anderson Multiple domains in caveolin-1 control its intracellular traffic J. Cell. Biol. 148 2000 17 28
54. X.H. Sun, D.C. Flynn, V. Castranova, L.L. Millecchia, A.R. Beardsley, and J. Liu Identification of a novel domain at the N-terminus of caveolin-1 that controls rear polarization of the protein and caveolae formation J. Biol. Chem. 282 2007 7232 7241
55. H.L. Chen, L.F. Fan, J. Gao, J.P. Ouyang, and Y.X. Zhang Differential expression and function of the caveolin-1 gene in non-small cell lung carcinoma Oncol. Rep. 25 2011 359 366
56. J. Couet, S. Li, T. Okamoto, T. Ikezu, and M.P. Lisanti Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins J. Biol. Chem. 272 1997 6525 6533
57. G. Garcia-Cardena, P. Martasek, B.S. Siler-Masters, P.M. Skidd, J.C. Couet, S. Li, M.P. Lisanti, and W.C. Sessa Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the nos caveolin binding domain in vivo J. Biol. Chem. 272 1997 25437 25440
58. R.S. Ostrom, and P.A. Insel The evolving role of lipid rafts and caveolae in G protein-coupled receptor signaling: implications for molecular pharmacology Br. J. Pharmacol. 143 2004 235 245
59. J.A. Engelman, R.J. Lee, A. Karnezis, D.J. Bearss, M. Webster, P. Siegel, W.J. Muller, J.J. Windle, R.G. Pestell, and M.P. Lisantii Reciprocal regulation of neu tyrosine kinase activity and caveolin-1 protein expression in vitro and in vivo: Implications for human breast cancer J. Biol. Chem. 273 1998 20448 20455
60. L. Druhan, K. Karuppiah, C.A. Chen, T. Smith, J.L. Zweier, W.C. Sessa, and A.J. Cardounel Suppression of eNOS-derived superoxide by caveolin-1: a biopterin-dependent mechanism Am. J. Physiol. Heart Circ. Physiol. 301 2011 H903 H911
61. X. Wang, S. Feng, H. Zhang, Y. Wang, Y. Cui, Z. Wang, J. Liu, and W. Zou RNA inference-mediated caveolin-1 down-regulation decrease estrogen receptor alpha (ERα) signaling in human mammary epithelial cells Mol. Biol. Rep. 38 2011 761 768
62. X. Zhang, M.T. Ling, Q. Wang, C.K. Lau, S.C. Leung, T.K. Lee, A.L. Cheung, Y.C. Wong, and X. Wang Identification of a novel inhibitor of differentiation-1 (ID-1) binding partner, caveolin-1, and its role in epithelial-mesenchymal transition and resistance to apoptosis in prostate cancer cells J. Biol. Chem. 282 2007 33284 33294
63. S.K. Miyasato, J. Loeffler, R. Shohet, J. Zhang, M. Lindsey, and C.J. Le Saux Caveolin-1 modulates TGF-β1 signaling in cardiac remodeling Matrix Biol. 30 2011 318 329
64. A.S. Martins, J.L. Ordóñez, A.T. Amaral, F. Prins, G. Floris, M. Debiec-Rychter, P.C. Hogendoorn, and E. de Alava IGF1R signaling in Ewing sarcoma is shaped by clathrin-/caveolin-dependent endocytosis PLoS One 6 2011 19846 19857
65. L. Zhang, Y. Wang, L. Wang, T. Cao, S. Hyuga, T. Sato, Y. Wu, S. Yamagata, and T. Yamagata Ganglioside GD1a negatively regulates hepatocyte growth factor expression through caveolin-1 at the transcriptional level in murine osteosarcoma cells Biochim. Biophys. Acta 1810 2011 759 768
66. B.M.1 Collins, M.J. Davis, J.F. Hancock, and R.G. Parton Structure-based reassessment of the caveolin signaling model: do caveolae regulate signaling through caveolin-protein interactions? Dev. Cell. 23 2012 11 20
67. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 5 2011 646 674
68. T.M. Williams, G.S. Hassan, J. Li, A.W. Cohen, F. Medina, P.G. Frank, R.G. Pestell, D. Di Vizio, M. Loda, and M.P. Lisanti Caveolin-1 promotes tumor progression in an autochthonous mouse model of prostate cancer: genetic ablation of Cav-1 delays advanced prostate tumor development in tramp mice J. Biol. Chem. 280 2005 25134 25145
69. K. Quann, D.M. Gonzales, I. Mercier, C. Wang, F. Sotgia, R.G. Pestell, M.P. Lisanti, and J.F. Jasmin Caveolin-1 is a negative regulator of tumor growth in glioblastoma and modulates chemosensitivity to temozolomide Cell. Cycle 12 10 2013 1510 1520
70. J.A. Engelman, C.C. Wykoff, S. Yashuhara, K.S. Song, T. Okamato, and M.P. Lisanti Recombinant expression of caveolin-1 in oncogenically transformed cells abrogates anchorage-independent growth J. Biol. Chem. 272 1997 16374 16381
71. M. Sáinz-Jaspeado, J. Martin-Liberal, L. Lagares-Tena, S. Mateo-Lozano, X. Garcia del Muro, and O.M. Tirado Caveolin-1 in sarcomas: friend or foe? Oncotarget 2 4 2011 305 312
72. A.J. Koleske, D. Baltimore, and M.P. Lisanti Reduction of caveolin and caveolae in oncogenically transformed cells Proc. Natl. Acad. Sci. U S A 92 1995 1381 1385
73. S. Feng, Y. Wang, X. Wang, Z. Wang, Y. Cui, J. Liu, C. Zhao, M. Jin, and W. Zou Caveolin-1 gene silencing promotes the activation of PI3K/AKT dependent on Eralpha36 and the transformation of MCF10ACE Sci. China Life Sci. 53 2010 598 605
74. F. Han, D. Gu, Q. Chen, and H. Zhu Caveolin-1 acts as a tumor suppressor by down-regulating epidermal growth factor receptor-mitogen-activated protein kinase signaling pathway in pancreatic carcinoma cell lines Pancreas 38 2009 766 774
75. F. Galbiati, D. Volonte, J.A. Engelman, G. Watanabe, R. Burk, R.G. Pestell, and M.P. Lisanti Targeted down-regulation of caveolin-1is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinasecascade EMBO J. 17 1998 6633 6648
76. D.T. Bau, M.H. Tsai, Y.A. Tsou, C.H. Wang, C.W. Tsai, S.S. Sun, C.H. Hua, S.K. Shyue, and R.Y. Tsai The association of caveolin-1 genotypes with oral cancer susceptibility in Taiwan Ann. Surg. Oncol. 18 2011 1431 1438
77. C.M. Hsu, M.D. Yang, C.W. Tsai, C.Y. Ho, W.S. Chang, S.C. Chang, L.B. Jeng, Y. Tsai, F.J. Tsai, and D.T. Bau The contribution of caveolin-1 genotype and phenotype to hepatocellular carcinoma Anticancer Res. 33 2013 671 677
78. F. Capozza, T.M. Williams, W. Schubert, S. McClain, B. Bouzahzah, F. Sotgia, and M.P. Lisanti Absence of caveolin-1 sensitizes mouse skin to carcinogen-induced epidermal hyperplasia and tumor formation Am. J. Pathol. 162 2003 2029 2039
79. H. Wikman, E. Kettunen, J.K. Seppanen, A. Karjalainen, J. Hollmen, S. Anttila, and S. Knuutila Identification of differentially expressed genes in pulmonary adenocarcinoma by using cDNA array Oncogene 21 2002 5804 5813
80. C. Racine, M. Belanger, H. Hirabayashi, M. Boucher, J. Chakir, and J. Couet Reduction of caveolin 1 gene expression in lung carcinoma cell lines Biochem Biophys. Res. Commun. 255 1999 580 586
81. S.W. Lee, C.L. Reimer, P. Oh, D.B. Campbell, and J.E. Schnitzer Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells Oncogene 16 1998 1391 1397
82. D.A. Zuccari, R. Castro, A.F. Gavioli, U.M. Mancini, C.S. Frade, and C. Leonel Immunohistochemical and molecular analysis of caveolin-1 expression in canine mammary tumors Genet. Mol. Res. 11 2012 153 165
83. F.C. Bender, M.A. Reymond, C. Bron, and A.F. Quest Caveolin-1 levels are down-regulated in human colon tumors, and ectopic expression of caveolin-1 in colon carcinoma cell lines reduces cell tumorigenicity Cancer Res. 60 2000 5870 5878
84. K. Wiechen, L. Diatchenko, A. Agoulnik, K.M. Scharff, H. Schober, K. Arlt, B. Zhumabayeva, P.D. Siebert, M. Dietel, R. Schafer, and C. Sers Caveolin-1 is downregulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene Am. J. Pathol. 159 2001 1635 1643
85. A.K. Witkiewicz, A. Dasgupta, F. Sotgia, I. Mercier, R.G. Pestell, M. Sabel, C.G. Kleer, J.R. Brody, and M.P. Lisanti An absence of stromal caveolin-1 expression predicts early tumor recurrence and poor clinical outcome in human breast cancers Am. J. Pathol. 174 2009 2023 2034
86. K. Wiechen, C. Sers, A. Agoulnik, K. Arlt, M. Dietel, P.M. Schlag, and U. Schneider Down-regulation of caveolin-1, a candidate tumor suppressor gene, in sarcomas Am. J. Pathol. 158 2001 833 839
87. L. Cantiani, M.C. Manara, C. Zucchini, P. De Sanctis, M. Zuntini, L. Valvassori, M. Serra, M. Olivero, M.F. Di Renzo, M.P. Colombo, P. Picci, and K. Scotlandi Caveolin-1 reduces osteosarcoma metastases by inhibiting c-Src activity and met signaling Cancer Res. 67 2007 7675 7685
88. D.A. Rodriguez, J.C. Tapia, J.G. Fernandez, V.A. Torres, N. Muñoz, D. Galleguillos, L. Leyton, and A.F. Quest Caveolin-1-mediated suppression of cyclooxygenase-2 via a beta-catenin-Tcf/Lef-dependent transcriptional mechanism reduced prostaglandin E2 production and survivin expression Mol. Biol. Cell. 20 2009 2297 2310
89. C.A. Hanson, K.R. Drake, M.A. Baird, B. Han, L.J. Kraft, M.W. Davidson, and A.K. Kenworthy Overexpression of caveolin-1 is sufficient to phenocopy the behavior of a disease-associated mutant Traffic 14 2013 663 677
90. P.E. Scherer, M.P. Lisanti, G. Baldini, M. Sargiacomo, C.C. Mastick, and H.F. Lodish Induction of caveolin during adipogenesis and association of GLUT4 with caveolinrich vesicles J. Cell. Biol. 127 1994 1233 1243
91. K. Hayashi, S. Matsuda, K. Machida, T. Yamamoto, Y. Fukuda, Y. Nimura, T. Hayakawa, and M. Hamaquchi Invasion activating caveolin-1 mutation in human scirrhous breast cancers Cancer Res. 61 2001 2361 2364
92. J. Cui, L.R. Rohr, G. Swanson, V.O. Speights, T. Maxwell, and A.R. Brothman Hypermethylation of the caveolin-1 gene promoter in prostate cancer Prostate 46 2001 249 256
93. X. Rao, J. Evans, H. Chae, J. Pilrose, S. Kim, P. Yan, R.L. Huang, H.C. Lai, H. Lin, Y. Liu, J.K. Rhee, Y.W. Huang, F. Gu, J.W. Gray, T.M. Huang, and K.P. Nephew CpG island shore methylation regulates caveolin-1 expression in breast cancer Oncogene 2012 10.1038/onc.2012.474
94. M.D. Yang, R.Y. Tsai, C.S. Liu, C.H. Chang, H.C. Wang, Y.A. Tsou, C.H. Wang, C.C. Lin, S.K. Shyue, and D.T. Bau Association of Caveolin-1 polymorphisms with colorectal cancer susceptibility in Taiwan World J. Gastrointest. Oncol. 2 2010 326 331
95. N. Syeed, S.A. Husain, S. Abdullah, A.S. Sameer, N.A. Chowdri, M.S. Nanda, and M.A. Siddiqi Mutational profile of the CAV-1 gene in breast cancer cases in the ethnic Kashmiri population Asian Pac. J. Cancer Prev. 11 2010 1099 1105
96. K.H. Nam, B.L. Lee, J.H. Park, J. Kim, N. Han, H.E. Lee, M.A. Kim, H.S. Lee, and W.H. Kim Caveolin 1 expression correlates with poor prognosis and focal adhesion kinase expression in gastric cancer Pathobiology 80 2013 87 94
97. R. Bartz, J. Zhou, J.T. Hsieh, Y. Ying, W. Li, and P. Liu Caveolin-1 secreting LNCaP cellsinduce tumor growth of caveolin-1 negative LNCaP cells in vivo Int. J. Cancer 122 2007 520 525
98. L. Li, G. Yang, S. Ebara, T. Satoh, Y. Nasu, T.L. Timme, C. Ren, J. Wang, S.A. Tahir, and T.C. Thompson Caveolin-1 mediates testosterone-stimulated survival/clonal growth and promotes metastatic activities in prostate cancer cells Cancer Res. 61 2001 4386 4392
99. S.A. Tahir, G. Yang, S. Ebara, T.L. Timme, T. Satoh, L. Li, A. Goltsov, M. Ittmann, J.D. Morrisett, and T.C. Thompson Secreted caveolin-1 stimulates cell survival/clonal growth and contributes to metastasis in androgen-insensitive prostate cancer Cancer Res. 61 2001 3882 3885
100. M.A. Del Pozo, N. Balasubramanian, N.B. Alderson, W.B. Kiosses, A. Grande-García, R.G. Anderson, and M.A. Schwartz Phospho-caveolin-1 mediates integrin-regulated membrane domain internalization Nat. Cell. Biol. 7 2005 901 908
101. Y. Nasu, T.L. Timme, G. Yang, C.H. Bangma, L. Li, C. Ren, S.H. Park, M. DeLeon, J. Wang, and T.C. Thompson Suppression of caveolin expression induces androgen sensitivity in metastatic androgen-insensitive mouse prostate cancer cells Nat. Med. 4 1998 1062 1064
102. T. Ando, H. Ishiguro, M. Kimura, A. Mitsui, Y. Mori, N. Sugito, K. Tomoda, R. Mori, K. Harada, T. Katada, R. Ogawa, Y. Fujii, and Y. Kuwabara The overexpression of caveolin- 1 and caveolin-2 correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma Oncol. Rep. 18 2007 601 609
103. W.T. Chiu, H.T. Lee, F.J. Huang, K.D. Aldape, J. Yao, P.S. Steeg, C.Y. Chou, Z. Lu, K. Xie, and S. Huang Caveolin-1 upregulation mediates suppression of primary breast tumor growth and brain metastases by Stat3 inhibition Cancer Res. 71 2011 4932 4943
104. S. Waalkes, H. Eggers, H. Blasig, F. Atschekzei, M.W. Kramer, J. Hennenlotter, W. Tränkenschuh, A. Stenzl, J. Serth, A.J. Schrader, M.A. Kuczyk, and A.S. Merseburger Caveolin-1 mRNA is overexpressed in malignant renal tissue and might serve as a novel diagnostic marker for renal cancer Biomark. Med. 5 2011 219 225
105. V. Barresi, S. Cerasoli, G. Paioli, E. Vitarelli, G. Giuffre, and G. Guiducci Caveolin-1 in meningiomas: expression and clinico-pathological correlations Acta Neuropathol. 112 2006 617 626
106. F. Pancotti, L. Roncuzzi, M. Maggiolini, and A. Gasperi-Campani Caveolin-1 silencing arrests the proliferation of metastatic lung cancer cells through the inhibition of STAT3 signaling Cell. Signal 24 2012 1390 1397
107. R. Senetta, C. Miracco, S. Lanzafame, L. Chiusa, R. Caltabiano, A. Galia, G. Stella, and P. Cassoni Epidermal growth factor receptor and caveolin-1 coexpression identifies adult supratentorial ependymomas with rapid unfavorable outcomes Neuro Oncol. 13 2011 176 183
108. K.G. Bryant, J. Camacho, J.F. Jasmin, C. Wang, S. Addya, M.C. Casimiro, P. Fortina, S. Balasubramaniam, K.E. Knudsen, R. Schwarting, M.P. Lisanti, and I. Mercier Caveolin-1 overexpression enhances androgen-dependent growth and proliferation in the mouse prostate Int. J. Biochem. Cell. Biol. 43 2011 1318 1329
109. J.A. Karam, Y. Lotan, C.G. Roehrborn, R. Ashfaq, P.I. Karakiewicz, and S.F. Shariat Caveolin-1 overexpression is associated with aggressive prostate cancer recurrence Prostate 67 2007 614 622
110. G. Yang, J. Addai, T.M. Wheeler, A. Frolov, B.J. Miles, D. Kadmon, and T.C. Thompson Correlative evidence that prostate cancer cell-derived caveolin-1 mediates angiogenesis Hum. Pathol. 38 2007 1688 1695
111. I. Steiner, K. Jung, K. Miller, C. Stephan, and A. Erbersdobler Expression of endothelial factors in prostate cancer: a possible role of caveolin-1 for tumour progression Oncol. Rep. 27 2012 389 395
112. Y. Lavie, G. Fiucci, and M. Liscovitch Up-regulation of caveolae and caveolar constituents in multidrug-resistant cancer J. Biol. Chem. 273 1998 32380 32383
113. G. Fiucci, D. Ravid, R. Reich, and M. Liscovitch Caveolin-1 inhibits anchorage-independent growth, anoikis and invasiveness in MCF-7human breast cancer cells Oncogene 21 2002 2365 2375
114. D. Ravid, S. Maor, H. Werner, and M. Liscovitch Caveolin-1 inhibits anoikis and promotes survival signaling in cancer cells Adv. Enzyme Regul. 46 2006 163 175
115. G. Yuan, I. Regel, F. Lian, T. Friedrich, I. Hitkova, R.D. Hofheinz, P. Ströbel, R. Langer, G. Keller, C. Röcken, W. Zimmermann, R.M. Schmid, M.P. Ebert, and E. Burgermeister WNT6 is a novel target gene of caveolin-1 promoting chemoresistance to epirubicin in human gastric cancer cells Oncogene 32 2013 375 387
116. M. Li, H. Chen, L. Diao, Y. Zhang, C. Xia, and F. Yang Caveolin-1 and VEGF-C promote lymph node metastasis in the absence of intratumoral lymphangiogenesis in non-small cell lung cancer Tumori 96 2010 734 743
117. S. Garcia, J.P. Dales, E. Charafe-Jauffret, S. Carpentier-Meunier, L. Andrac-Meyer, J. Jacquemier, C. Andonian, M.N. Lavaut, C. Allasia, P. Bonnier, and C. Charpin Poor prognosis in breast carcinomas correlates with increased expression of targetableCD146 and c-Met and with proteomic basal-like phenotype Hum. Pathol. 38 2007 830 841
118. T.K. Ha, N.G. Her, M.G. Lee, B.K. Ryu, J.H. Lee, J. Han, S.I. Jeong, M.J. Kang, N.H. Kim, H.J. Kim, and S.G. Chi Caveolin-1 increases aerobic glycolysis in colorectal cancers by stimulating HMGA1-mediated GLUT3 transcription Cancer Res. 72 2012 4097 4109
119. T.K. Ha, and S.G. Chi CAV1/caveolin 1 enhances aerobic glycolysis in colon cancer cells via activation of SLC2A3/GLUT3 transcription Autophagy 8 2012 1684 1685
120. K.A. Sloan, H.A. Marquez, J. Li, Y. Cao, A. Hinds, C.J. O'Hara, S. Kathuria, M.I. Ramirez, C.M. Williams, and H. Kathuria Increased PEA3/E1AF and decreased Net/Elk-3, both ETS proteins, characterize human NSCLC progression and regulate caveolin-1 transcription in Calu-1 and NCI-H23 NSCLC cell lines Carcinogenesis 30 2009 1433 1442
121. J.G. Goetz, B. Joshi, and P. Lajoie Concerted regulation of focal adhesion dynamics by galectin-3 and tyrosine phosphorylated caveolin-1 J. Cell. Biol. 180 2008 1261 1275
122. B. Annabi, M. Bouzeghrane, R. Moumdjian, A. Moghrabi, and R. Béliveau Probing the infiltrating character of brain tumors: inhibition of RhoA/ROK-mediated CD44 cell surface shedding from glioma cells by the green tea catechin EGCg J. Neurochem. 94 4 2005 906 916
123. B. Joshi, S.S. Strugnell, J.G. Goetz, M.E. Cox, O.L. Griffith, S.K. Chan, S.J. Jones, S.P. Leung, H. Masoudi, S. Leung, S.M. Wiseman, and I.R. Nabi Phosphorylated Caveolin-1 regulates Rho/ROCK-dependent focal adhesion dynamics and tumor cell migration and invasion Cancer Res. 68 2008 8210 8220
124. E. Arpaia, H. Blaser, M. Quintela-Fandino, G. Duncan, H.S. Leong, A. Ablack, S.C. Nambiar, E.F. Lind, J.J. Silvester, C.K. Fleming, A. Rufini, M.W. Tusche, A. Brüstle, P.S. Ohashi, J.D. Lewis, and T.W. Mak The interaction between caveolin-1 and Rho-GTPases promotes metastasis by controlling the expression of alpha5-integrin and the activation of Src, Ras and Erk Oncogene 31 2012 884 896
125. Y. Tang, X. Zeng, F. He, Y. Liao, N. Qian, and M. Toi Caveolin-1 is related to invasion, survival, and poor prognosis in hepatocellular cancer Med. Oncol. 29 2012 977 984
126. F. Felicetti, I. Parolini, L. Bottero, K. Fecchi, M.C. Errico, C. Raggi, M. Biffoni, F. Spadaro, M.P. Lisanti, M. Sargiacomo, and A. Carè Caveolin-1 tumor-promoting role in human melanoma Int. J. Cancer 125 2009 1514 1522
127. J.G. Goetz, S. Minguet, I. Navarro-Lérida, J.J. Lazcano, R. Samaniego, E. Calvo, M. Tello, T. Osteso-Ibáñez, T. Pellinen, A. Echarri, A. Cerezo, A.J. Klein-Szanto, R. Garcia, P.J. Keely, P. Sánchez-Mateos, E. Cukierman, and M.A. Del Pozo Biomechanical remodeling of the microenvironment by stromal caveolin-1 favors tumor invasion and metastasis Cell 146 2011 148 163
128. K.K. Wary, A. Mariotti, C. Zurzolo, and F.G. Giancotti A requirement for caveolin-1 and associated kinase Fyn in integrin signaling and anchorage-dependent cell growth Cell 94 1998 625 634
129. K. Gaus, S. Le Lay, N. Balasubramanian, and M.A. Schwartz Integrin-mediated adhesion regulates membrane order J. Cell. Biol. 174 2006 725 734
130. M. Nethe, and P.L. Hordijk A model for phospho-caveolin-1-driven turnover of focal adhesions Cell. Adh. Migr. 5 2011 59 64
131. C. Trimmer, D. Whitaker-Menezes, G. Bonuccelli, J.N. Milliman, K.M. Daumer, A.E. Aplin, R.G. Pestell, F. Sotgia, M.P. Lisanti, and F. Capozza CAV1 inhibits metastatic potential in melanomas through suppression of the integrin/Src/FAK signaling pathway Cancer Res. 70 2010 7489 7499
132. F. Galbiati, D. Volonté, J. Liu, F. Capozza, P.G. Frank, L. Zhu, R.G. Pestell, and M.P. Lisanti Caveolin-1 expression negatively regulates cell cycle progression by inducing G(0)/G(1) arrest via a p53/p21(WAF1/Cip1)-dependent mechanism Mol. Biol. Cell. 12 2001 2229 2244
133. A.N. Shajahan, A. Wang, M. Decker, R.D. Minshall, M.C. Liu, and R. Clarke Caveolin-1 tyrosine phosphorylation enhances paclitaxel-mediated cytotoxicity J. Biol. Chem. 282 8 2007 5934 5943
134. A. Linge, P. Meleady, M. Henry, M. Clynes, M. Kasper, and K. Barth Bleomycin treatment of A549 human lung cancer cells results in association of MGr1-Ag and caveolin-1 in lipid rafts Int. J. Biochem. Cell. Biol. 43 2011 98 105
135. T. Songserm, V. Pongrakhananon, and P. Chanvorachote Sub-toxic cisplatin mediates anoikis resistance through hydrogen peroxide-induced caveolin-1 up-regulation in non-small cell lung cancer cells Anticancer Res. 32 2012 1659 1669
136. P. Rungtabnapa, U. Nimmannit, H. Halim, Y. Rojanasakul, and P. Chanvorachote Hydrogen peroxide inhibits non-small cell lung cancer cell anoikis through the inhibition of caveolin-1 degradation Am. J. Physiol. Cell. Physiol. 300 2011 C235 C245
137. C.J. Percy, B.K. Pat, H. Healy, D.W. Johnson, and G.C. Gobe Phosphorylation of caveolin-1 is anti-apoptotic and promotes cell attachment during oxidative stress of kidney cells Pathology 40 2008 694 701
138. H. Zou, D. Volonte, and F. Galbiati Interaction of caveolin-1 with Ku70 inhibits Bax-mediated apoptosis PloS One 7 2012 e39379
139. X. Zhao, Y. Liu, Q. Ma, X. Wang, H. Jin, M. Mehrpour, and Q. Chen Caveolin-1 negatively regulates TRAIL-induced apoptosis in human hepatocarcinoma cells Biochem. Biophys. Res. Commun. 378 2009 21 26
140. S. Wang, L. Jia, H. Zhou, X. Wang, and J. Zhang Caveolin-1 promotes the transformation and anti-apoptotic ability of mouse hepatoma cells IUBMB Life 60 2008 693 699
141. D. Ravid, S. Maor, H. Werner, and M. Liscovitch Caveolin-1 inhibits cell detachment-induced p53 activation and anoikis by upregulation of insulin-like growth factor-I receptors and signaling Oncogene 24 2005 1338 1347
142. C. Glait, L. Tencer, D. Ravid, R. Sarfstein, M. Liscovitch, and H. Werner Caveolin-1 up-regulates IGF-I receptor gene transcription in breast cancer cells via Sp1- and p53-dependent pathways Exp. Cell. Res. 312 2006 3899 3908
143. M. Zhang, S.J. Lee, C. An, J.F. Xu, B. Joshi, I.R. Nabi, A.M. Choi, and Y. Jin Caveolin-1 mediates Fas-BID signaling in hyperoxia-induced apoptosis Free Radic. Biol. Med. 50 2011 1252 1262
144. E.J. Jung, and C.W. Kim Caveolin-1 inhibits TrkA-induced cell death by influencing on TrkA modification associated with tyrosine-490 phosphorylation Biochem. Biophys. Res. Commun. 402 2010 736 741
145. J. Park, E. Bae, C. Lee, S.S. Yoon, Y.S. Chae, K.S. Ahn, and N.H. Won RNA interference-directed caveolin-1 knockdown sensitizes SN12CPM6 cells to doxorubicin-induced apoptosis and reduces lung metastasis Tumor Biol. 31 2010 643 650
146. P.E. Scherer, T. Okamoto, M. Chun, I. Nishimoto, H.F. Lodish, and M.P. Lisanti Identification, sequence and expression of caveolin-2 defines a caveolin gene family Proc. Natl. Acad. Sci. U S A 93 1996 131 135
147. M.A. Aldred, M.E. Ginn-Pease, C.D. Morrison, A.P. Popkie, O. Gimm, C. Hoang-Vu, U. Krause, H. Dralle, S.M. Jhiang, C. Plass, and C. Eng Caveolin-1 and caveolin-2,together with three bone morphogenetic protein-related genes, may encode novel tumor suppressors down-regulated in sporadic follicular thyroid carcinogenesis Cancer Res. 63 2003 2864 2871
148. K.A. McMahon, H. Zajicek, W.P. Li, M.J. Peyton, J.D. Minna, V.J. Hernandez, L.K. Phelps, and R.G. Anderson SRBC/cavin-3 is a caveolin adapter protein that regulates caveolae function EMBO J. 28 2009 1001 1015
149. P.E. Scherer, R.Y. Lewis, D. Volonte, J.A. Engelman, F. Galbiati, J. Couet, D.S. Kohtz, E. van Donselaar, P. Peters, and M.P. Lisanti Cell-type and tissue-specific expression of caveolin-2. Caveolins 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo J. Biol. Chem. 272 1997 29337 29346
150. L.L. Zhu, Y. Cui, Y.S. Chang, and F.D. Fang A second protein marker of caveolae: caveolin-2 Chin. Med. Sci. J. 25 2010 119 124
151. M. Hahn-Obercyger, L. Graeve, and Z. Madar A high-cholesterol diet increases the association between caveolae and insulin receptors in rat liver J. Lipid Res. 50 2009 98
152. I. Parolini, M. Sargiacomo, F. Galbiati, G. Rizzo, F. Grignani, J.A. Engelman, T. Okamoto, T. Ikezu, P.E. Scherer, and R. Moraet Expression of caveolin-1 is required for the transport of caveolin-2 to the plasma membrane. Retention of caveolin-2 at the level of the golgi complex J. Biol. Chem. 274 1999 25718 25725
153. M.P. Lisanti, P.E. Scherer, Z. Tang, and M. Sargiacomo Caveolae, caveolin and caveolin-rich membrane domains: a signalling hypothesis Trends Cell. Biol. 4 1994 231 235
154. L. Breuza, S. Corby, J.P. Arsanto, M.H. Delgrossi, P. Scheiffele, and A. Le Bivic The scaffolding domain of caveolin 2 is responsible for its golgi localization in caco-2 cells J. Cell. Sci. 115 2002 4457 4467
155. X.H. Sun, Z.Y. Liu, H. Chen, A.R. Beardsley, Q. Qi, and J.A. Liu conserved sequence in caveolin-1 is both necessary and sufficient for caveolin polarity and cell directional migration FEBS Lett. 583 2009 3681 3689
156. H. Kwon, K. Jeong, and Y. Pak Identification of pY19-caveolin-2 as a positive regulator of insulin-stimulated actin cytoskeleton-dependent mitogenesis J. Cell. Mol. Med. 13 2009 1549 1564
157. S. Lee, H. Kwon, K. Jeong, and Y. Pak Regulation of cancer cell proliferation by caveolin-2 down-regulation and re-expression Int. J. Oncol. 38 2011 1395 1402
158. D. Kim, H. Kim, and J.S. Koo Expression of caveolin-1, caveolin-2 and caveolin-3 in thyroid cancer and stroma Pathobiology 79 2012 1 10
159. Y.C. Hu, K.Y. Lam, S. Law, J. Wong, and G. Srivastava Profiling of differentially expressed cancer-related genes in esophageal squamous cell carcinoma (ESCC) using human cancer cDNA arrays: overexpression of oncogene MET correlates with tumor differentiation in ESCC Clin. Cancer Res. 7 11 2001 3519 3525
160. A. Fong, E. Garcia, L. Gwynn, M.P. Lisanti, M.J. Fazzari, and M. Li Expression of caveolin-1 and caveolin-2 in urothelial carcinoma of the urinary bladder correlates with tumor grade and squamous differentiation Am. J. Clin. Pathol. 120 1 2003 93 100
161. R. Hnasko, and M.P. Lisanti The biology of caveolae: lessons from caveolin knockout mice and implications for human disease Mol. Interv. 3 8 2003 445 464
162. L. Xie, P.G. Frank, M.P. Lisanti, and G. Sowa Endothelial cells isolated from caveolin-2 knockout mice display higher proliferation rate and cell cycle progression relative to their wild-type counterparts Am. J. Physiol. Cell. Physiol. 298 2010 C693 C701
163. S.E. Elsheikh, A.R. Green, E.A. Rakha, R.M. Samaka, A.A. Ammar, D. Powe, J.S. Reis-Filho, and I.O. Ellis Caveolin 1 and caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotype Br. J. Cancer 99 2008 327 334
164. Y. Sagara, K. Mimori, K. Yoshinaga, F. Tanaka, K. Nishida, S. Ohno, H. Inoue, and M. Mori Clinical significance of Caveolin-1, Caveolin-2 and HER2/neu mRNA expression in human breast cancer Br. J. Cancer 91 2004 959 965
165. W.I. Silva, H.M. Maldonado, G. Velazquez, M. Rubio-Davila, J.D. Miranda, E. Aquino, N. Mayol, A. Cruz-Torres, J. Jardon, and I.K. Salgado-Villanueva Caveolin isoform expression during differentiation of C6 glioma cells Int. J. Dev. Neurosci. 23 2005 599 612
166. T. Yamasaki, N. Seki, H. Yoshino, T. Itesako, H. Hidaka, Y. Yamada, S. Tatarano, T. Yonezawa, T. Kinoshita, M. Nakagawa, and H. Enokida MicroRNA-218 inhibits cell migration and invasion in renal cell carcinoma through targeting Caveolin-2 involved in focal adhesion pathway J. Urol. 190 2013 1059 1068
167. Z. Tang, P.E. Scherer, T. Okamoto, K. Song, C. Chu, D.S. Kohtz, I. Nishimoto, H.F. Lodish, and M.P. Lisanti Molecular cloning of caveolin- 3, a novel member of the caveolin gene family expressed predominantly in muscle J. Biol. Chem. 271 1996 2255 2261
168. S.R. Fuhs, and P.A. Insel Caveolin-3 undergoes SUMOylation by the SUMO E3 ligase PIASy: sumoylation affects G-protein-coupled receptor desensitization J. Biol. Chem. 286 2011 14830 14841
169. K.S. Song, P.E. Scherer, Z. Tang, T. Okamoto, S. Li, M. Chafel, C. Chu, D.S. Kohtz, and M.P. Lisanti Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins J. Biol. Chem. 271 1996 15160 15165
170. V.O. Rybin, X. Xu, M.P. Lisanti, and S.F. Steinberg Differential targeting of beta -adrenergic receptor subtypes and adenylyl cyclase to cardiomyocyte caveolae. A mechanism to functionally regulate the cAMP signaling pathway J. Biol. Chem. 275 2000 41447 41457
171. Y.T. Horikawa, M. Panneerselvam, Y. Kawaraguchi, Y.M. Tsutsumi, S.S. Ali, R.C. Balijepalli, F. Murray, B.P. Head, I.R. Niesman, T. Rieg, V. Vallon, P.A. Insel, H.H. Patel, and D.M. Roth Cardiac-specific over-expression of caveolin-3 attenuates cardiac hypertrophy and increases natriuretic peptide expression and signaling J. Am. Coll. Cardiol. 57 2011 2273 2283
172. E. Stoppani, S. Rossi, E. Meacci, F. Penna, P. Costelli, A. Bellucci, F. Faggi, D. Maiolo, E. Monti, and A. Fanzani Point mutated caveolin-3 form (P104L) impairs myoblast differentiation via Akt and p38 signalling reduction, leading to an immature cell signature Biochim. Biophys. Acta 1812 2011 468 479
173. A. Kuga, Y. Ohsawa, T. Okada, F. Kanda, M. Kanagawa, T. Toda, and Y. Sunada Endoplasmic reticulum stress response in P104L mutant caveolin-3 transgenic mice Hum. Mol. Genet. 20 2011 2975 2983
174. B. Razani, J.A. Engelman, X.B. Wang, W. Schubert, X.L. Zhang, C.B. Marks, F. Macaluso, R.G. Russell, M. Li, R.G. Pestell, D.D. Vizio, H. Hou, H.B. Kneitz, G. Lagaud, G.J. Christ, W. Edelmann, and M.P. Lisanti Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities J. Biol. Chem. 276 2001 38121 38138
175. M. Drab, P. Verkade, M. Elger, M. Kasper, M. Lohn, B. Lauterbach, J. Menne, C. Lindschau, F. Mende, F.C. Luft, A. Schedl, H. Haller, and T.V. Kurzchalia Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice Science 293 2001 2449 2452
176. F. Galbiati, J.A. Engelman, D. Volonte, X.L. Zhang, C. Minetti, M. Li, H. Hou, B. Kneitz, W. Edelmann, and M.P. Lisanti Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and t-tubule abnormalities J. Biol. Chem. 276 2001 21425 21433
177. D.S. Park, S.E. Woodman, W. Schubert, A.W. Cohen, P.G. Frank, M. Chandra, J. Shirani, B. Razani, B. Tang, L.A. Jelicks, S.M. Factor, L.M. Weiss, H.B. Tanowitz, and M.P. Lisanti Caveolin-1/3 double-knockout mice are viable, but lack both muscle and non-muscle caveolae, and develop a severe cardiomyopathic phenotype Am. J. Pathol. 160 2002 2207 2217
178. B. Nolwenn, D. Isabelle, and L.L. Oazig Cavin proteins: new players in the caveolae field Biochimie 93 2011 71 77
179. P. Jansa, S.W. Mason, U. Hoffmann-Rohrer, and I. Grummt Cloning and functional characterization of PTRF, a novel protein which induces dissociation of paused ternary transcription complexes EMBO J. 17 1998 2855 2864
180. L. Liu, and P.F. Pilch A critical role of cavin (polymerase I and transcript release factor) in caveolae formation and organization J. Biol. Chem. 283 2007 4314 4322
181. K.L. Inder, Y.Z. Zheng, M.J. Davis, H. Moon, D. Loo, H. Nguyen, J.A. Clements, R.G. Parton, L.J. Foster, and M.M. Hill Expression of PTRF in PC-3 Cells modulates cholesterol dynamics and the actin cytoskeleton impacting secretion pathways Mol. Cell. Proteomics 11 2012 10.1074/mcp.M111.012245 M111.012245
182. R. Burgener, M. Wolf, T. Ganz, and M. Baggiolini Purification and characterization of a major phosphatidylserine-binding phosphoprotein from human platelets Biochem. J. 1990 729 734
183. A. Hayer, M. Stoeber, C. Bissig, and A. Helenius Biogenesis of caveolae: stepwise assembly of large caveolin and cavin complexes Traffic 11 2010 361 382
184. S. Gustincich, P. Vatta, S. Goruppi, M. Wolf, S. Saccone, G. Della Valle, M. Baggiolini, and C. Schneider The human serum deprivation response gene (SDPR) maps to 2q32-q33 and codes for a phosphatidylserine-binding protein Genomics 1999 120 129
185. C. Mineo, Y.S. Ying, C. Chapline, S. Jaken, and R.G. Anderson Targeting of protein kinase Cα to caveolae J. Cell. Biol. 141 1998 601 610
186. C.G. Hansen, N.A. Bright, G. Howard, and B.J. Nichols SDPR induces membrane curvature and functions in the formation of caveolae Nat. Cell. Biol. 11 2009 807 814
187. C.G. Hansen, and B.J. Nichols Exploring the caves: cavins, caveolins and caveolae Trends Cell. Biol. 20 2010 177 186
188. W. Romer, L. Berland, V. Chambon, K. Gaus, B. Windschiegl, D. Tenza, M.R. Aly, V. Fraisier, J.C. Florent, D. Perrais, C. Lamaze, G. Raposo, C. Steinem, P. Sens, P. Bassereau, and L. Johannes Shiga toxin induces tubular membrane invaginations for its uptake into cells Nature 450 2007 670 675
189. M. Bauer, and L. Pelkmans A new paradigm for membrane-organizing and - shaping scaffolds FEBS Lett. 580 2006 5559 5564
190. J. Zimmerberg, and M.M. Kozlov How proteins produce cellular membrane curvature Nat. Rev. Mol. Cell. Biol. 7 2006 9 19
191. Y. Izumi, S. Hirai, Y. Tamai, A. Fujise-Matsuoka, Y. Nishimura, and S. Ohno A protein kinase Cdelta-binding protein SRBC whose expression is induced by serum starvation J. Biol. Chem. 272 1997 7381 7389
192. X.L. Xu, L.C. Wu, F. Du, A. Davis, M. Peyton, Y. Tomizawa, A. Maitra, G. Tomlinson, A.F. Gazdar, B.E. Weissman, A.M. Bowcock, R. Baer, and J.D. Minna Inactivation of human SRBC, located within the 11p15.5-p15.4 tumor suppressor region, in breast and lung cancers Cancer Res. 61 2001 7943 7949
193. C. Minetti, M. Bado, P. Broda, F. Sotgia, C. Bruno, F. Galbiati, D. Volonte, G. Lucania, A. Pavan, E. Bonilla, M.P. Lisanti, and G. Cordone Impairment of caveolae formation and T-system disorganization in human muscular dystrophy with caveolin-3 deficiency Am. J. Pathol. 160 2002 265 270
194. T. Ogata, T. Ueyama, K. Isodono, M. Tagawa, N. Takehara, T. Kawashima, K. Harada, T. Takahashi, T. Shioi, H. Matsubara, and H. Oh MURC, a muscle-restricted coiled-coil protein that modulates the Rho/ROCK pathway, induces cardiac dysfunction and conduction disturbance Mol. Cell. Biol. 28 2008 3424 3436
195. M. Tagawa, T. Ueyama, T. Ogata, N. Takehara, N. Nakajima, K. Isodono, S. Asada, T. Takahashi, H. Matsubara, and H. Oh MURC, a muscle-restricted coiled-coil protein, is involved in the regulation of skeletal myogenesis Am. J. Physiol. Cell. Physiol. 295 2008 490 498
196. B. Thisse, and C. Thisse Fast Release Clones: a High Throughput Expression Analysis 2004 (ZFIN Direct Data Submission)
197. M. Bastiani, L. Liu, M.M. Hill, M.P. Jedrychowski, S.J. Nixon, H.P. Lo, D. Abankwa, R. Luetterforst, M. Fernandez-Rojo, M.R. Breen, S.P. Gygi, J. Vinten, P.J. Walser, K.N. North, J.F. Hancock, P.F. Pilch, and R.G. Parton MURC/Cavin-4 and cavin family members form tissue-specific caveolar complexes J. Cell. Biol. 185 2009 1259 1273
198. L. Liu, H.X. Xu, W.Q. Wang, C.T. Wu, T. Chen, Y. Qin, C. Liu, J. Xu, J. Long, B. Zhang, Y.F. Xu, Q.X. Ni, M. Li, and X.J. Yu Cavin-1 is essential for the tumor-promoting effect of caveolin-1 and enhances its prognostic potency in pancreatic cancer Oncogene 2013 Jun 17 10.1038/onc.2013.223
199. E. Tahanian, L.A. Sanchez, T.C. Shiao, R. Roy, and B. Annabi Flavonoids targeting of IκB phosphorylation abrogates carcinogen-induced MMP-9 and COX-2 expression in human brain endothelial cells Drug. Des. Dev. Ther. 5 2011 299 309
200. E. Tahanian, S. Peiro, and B. Annabi Low intracellular ATP levels exacerbate carcinogen-induced inflammatory stress response and inhibit in vitro tubulogenesis in human brain endothelial cells J. Inflamm. Res. 4 2011 1 10
201. C.S. Aung, M.M. Hill, M. Bastiani, R.G. Parton, and M.O. Parat PTRF-cavin-1 expression decreases the migration of PC3 prostate cancer cells: role of matrix metalloprotease 9 Eur. J. Cell. Biol. 90 2011 136 142
202. M.L. Gould, G. Williams, and H.D. Nicholson Changes in caveolae, caveolin, and polymerase 1 and transcript release factor (PTRF) expression in prostate cancer progression Prostate 70 2010 1609 1621
203. J.S. Yi, D.G. Mun, H. Lee, J.S. Park, J.W. Lee, J.S. Lee, S.J. Kim, B.R. Cho, S.W. Lee, and Y.G. Ko PTRF/Cavin-1 is essential for multidrug resistance in cancer cells J. Proteome Res. 12 2013 605 614
204. A. Gámez-Pozo, I. Sánchez-Navarro, E. Calvo, M.T. Agulló-Ortuño, R. López-Vacas, E. Díaz, E. Camafeita, M. Nistal, R. Madero, E. Espinosa, J.A. López, and J.A. Fresno Vara PTRF/cavin-1 and MIF proteins are identified as non-small cell lung cancer biomarkers by label-free proteomics PLoS One 7 2012 e33752 e33761
205. D. Volonte, and F. Galbiati Polymerase I and transcript release factor (PTRF)/cavin-1, a novel regulator of stress-induced premature senescence J. Biol. Chem. 286 2011 28657 28661
206. P. Verma, A.G. Ostermeyer-Fay, and D.A. Brown Caveolin-1 induces formation of membrane tubules that sense actomyosin tension and are inhibited by polymerase I and transcript release factor/cavin-1 Mol. Biol. Cell. 21 2010 2226 2240
207. J.H. Lee, D.S. Byun, M.G. Lee, B.K. Ryu, M.J. Kang, K.S. Chae, K.Y. Lee, H.J. Kim, H. Park, and S.G. Chi Frequent epigenetic inactivation of hSRBC in gastric cancer and its implication in attenuated p53 response to stresses Int. J. Cancer 122 2008 1573 1584
208. S. Zochbauer-Muller, K.M. Fong, J. Geradts, X. Xu, S. Seidl, A. End-Pfutzenreuter, G. Lang, G. Heller, C.C. Zielinski, A.F. Gazdar, and J.D. Minna Expression of the candidate tumor suppressor gene hSRBC is frequently lost in primary lung cancers with and without DNA methylation Oncogene 24 2005 6249 6255
209. L. Bai, X. Deng, Q. Li, M. Wang, W. An, A. Deli, Z. Gao, Y. Xie, Y. Dai, and Y.S. Cong Down-regulation of the cavin family proteins in breast cancer J. Cell. Biochem 113 2012 322 328
210. H. Lee, D. Volonte, F. Galbiati, P. Iyengar, D.M. Lublin, D.B. Bregman, M.T. Wilson, R. Campos-Gonzalez, B. Bouzahzah, R.G. Pestell, P.E. Scherer, and M.P. Lisanti Constitutive and growth factor-regulated phosphorylation of caveolin-1 occurs at the same site (Tyr-14) in vivo: identification of a c-Src/Cav-1/Grb7 signaling cassette Mol. Endocrinol. 14 2000 1750 1775
211. H. Lee, D.S. Park, X.B. Wang, P.E. Scherer, P.E. Schwartz, and M.P. Lisanti Src-induced phosphorylation of caveolin-2 on tyrosine 19. Phospho-caveolin-2 [Tyr(P)19] is localized near focal adhesions, remains associated with lipid rafts/caveolae, but no longer forms a high molecular mass hetero-oligomer with caveolin-1 J. Biol. Chem. 277 2002 34556 34567
212. S.A. Tahir, G. Yang, A.A. Goltsov, M. Watanabe, K. Tabata, J. Addai, M.A. Fattah el, D. Kadmon, and T.C. Thompson Tumor cell-secreted caveolin-1 has proangiogenic activities in prostate cancer Cancer Res. 68 2008 731 739
213. H. Ju, R. Zou, V.J. Venema, and R.C. Venema Direct interaction of endothelial nitric-oxide synthase and caveolin-1 inhibits synthase activity J. Biol. Chem. 272 1997 18522 18525
214. Z. Lu, S. Ghosh, Z. Wang, and T. Hunter Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion Cancer Cell. 4 2003 499 515
215. G. Ayala, M. Morello, A. Frolov, S. You, R. Li, F. Rosati, G. Bartolucci, G. Danza, R.M. Adam, T.C. Thompson, M.P. Lisanti, M.R. Freeman, and D. Di Vizio Loss of caveolin-1 in prostate cancer stroma correlates with reduced relapse-free survival and its functionally relevant to tumor progression J. Pathol. 231 2013 77 87
216. C. Meyer, Y. Liu, A. Kaul, I. Peipe, and S. Dooley Caveolin-1 abrogates TGF-βmediated hepatocyte apoptosis Cell. Death Dis. 4 2013 e 466 10.1038/cddis.2012.204
217. K. Quann, D.M. Gonzales, I. Mercier, C. Wang, F. Sotgia, R.G. Pestell, M.P. Lisanti, and J.F. Jasmin Caveolin-1 is a negative regulator of tumor growth in glioblastoma and modulates Cell. Cycle 12 2013 1510 1520
218. C. Trimmer, G. Bonuccelli, S. Katiyar, F. Sotgia, R.G. Pestell, M.P. Lisanti, and F. Capozza Cav1 suppresses tumor growth and metastasis ina murine model of cutaneous SCC through modulation ofMAPK/AP-1 activation Am. J. Pathol. 182 2013 992 1004
219. A. Puyraimond, R. Fridman, M. Lemesle, B. Arbeille, and S. Menashi MMP-2 colocalizes with caveolae on the surface of endothelial cells Exp. Cell. Res. 262 2001 28 36
220. C. Pramudji, S. Shimura, S. Ebara, G. Yang, J. Wang, C. Ren, Y. Yuan, S.A. Tahir, T.L. Timme, and T.C. Thompson In situ prostate cancer gene therapy using a novel adenoviral vector regulated by the caveolin-1 promoter Clin. Cancer Res. 7 2001 4272 4279
221. J.P. Gratton, M.I. Lin, J. Yu, E.D. Weiss, Z.L. Jiang, T.A. Fairchild, Y. Iwakiri, R. Groszmann, K.P. Claffey, Y.C. Cheng, and W.C. Sessa Selective inhibition of tumor microvascular permeability by cavtratin blocks tumor progression in mice Cancer Cell. 4 2003 31 39
222. M. Hamoudane, S. Maffioli, R. Cordera, D. Maggi, and B. Salani Caveolin-1 and polymerase I and transcript release factor: new players in insulin-like growth factor-I receptor signaling J. Endocrinol. Invest 36 2013 204 208
223. H. Moon, C.S. Lee, K.L. Inder, S. Sharma, E. Choi, D.M. Black, K.A. Lê Cao, C. Winterford, J.I. Coward, M.T. Ling, D.J. Craik, R.G. Parton, P.J. Russell, and M.M. Hill PTRF/cavin-1 neutralizes non-caveolar caveolin-1 microdomains in prostate cancer Oncogene 33 27 2014 3561 3570
224. K.L. Inder, Y.Z. Zheng, M.J. Davis, H. Moon, D. Loo, H. Nguyen, J.A. Clements, R.G. Parton, L.J. Foster, and M.M. Hill Expression of PTRF in PC-3 cells modulates cholesterol dynamics and the actin cytoskeleton impacting secretion pathways Mol. Cell. Proteomics 11 2 2012 Feb M111.012245
225. M.M. Hill, N.H. Daud, C.S. Aung, D. Loo, S. Martin, S. Murphy, D.M. Black, R. Barry, F. Simpson, L. Liu, P.F. Pilch, J.F. Hancock, M.O. Parat, and R.G. Parton Co-regulation of cell polarization and migration by caveolar proteins PTRF/Cavin-1 and caveolin-1 PLoS One 7 2012 e43041
226. X. Li, Z. Jia, Y. Shen, H. Ichikawa, J. Jarvik, R.G. Nagele, and G.S. Goldberg Coordinate suppression of Sdpr and Fhl1 expression in tumors of the breast, kidney, and prostate Cancer Sci. 99 2008 1326 1333
227. Jin-Hee Lee, Min-Ju Kang, Hye-Yeon Han, Min-Goo Lee, Seong-In Jeong, Byung-Kyu Ryu, Tae-Kyu Ha, Nam-Goo Her, Jikhyon Han, Sun Jin Park, Kil Yeon Lee, Hyo-Jong Kim, and Sung-Gil Chi Epigenetic alteration of PRKCDBP in colorectal cancers and its implication in tumor cell resistance to TNFα-induced apoptosis Clin. Cancer Res. 17 December, 2011 7551
228. X.L. Xu, L.C. Wu, F. Du, A. Davis, M. Peyton, and Y. Tomizawa Inactivation of human SRBC, located within the 11p15.5-p15.4 tumor suppressor region, in breast and lung cancers Cancer Res. 61 2001 7943 7949
229. J.H. Lee, D.S. Byun, M.G. Lee, B.K. Ryu, M.J. Kang, and K.S. Chae Frequent epigenetic inactivation of hSRBC in gastric cancer and its implication in attenuated p53 response to stresses Int. J. Cancer 122 2008 1573 1584
230. Y. Ogawara, S. Kishishita, T. Obata, Y. Isazawa, T. Suzuki, and K. Tanaka Akt enhances Mdm2-mediated ubiquitination and degradation of p53 J. Biol. Chem. 277 2002 21843 21850
231. S. Paskaš, J. Janković, I. Marečko, T.I. Denčić, S. STatić, D. Cvejić, and S. Savin Caveolin-1 expression in papillary thyroid carcinoma: correlation with clinicopathological parameters and BRAF mutation status Otolaryngol. Head. Neck Surg. 150 2014 201 209
232. V.D. Eynden Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer Breast Cancer Res. Treat. 95 2005 219 228
233. F. Bianchi, J. Hu, G. Pelosi, R. Cirincione, M. Ferguson, C. Ratcliffe, P. Paolo, D. Fiore, K. Gatter, F. Pezzella, and U. Pastorino Lung cancers detected by screening with spiral computed tomography have a malignant phenotype when analyzed by cDNA microarray Clin. Cancer Res. 10 2004 6023 6028
234. H.N. Choi, K.R. Kim, H.S. Park, K.Y. Jang, M.J. Kang, D.G. Lee, Y.K. Kim, B.H. Cho, E.J. Cha, and W.S. Moon Expression of caveolin in hepatocellular carcinoma: association with unpaired artery formation and radiologic findings Korean J. Hepatol. 13 2007 396 408
235. G. Yang, A. Goltsov, C. Ren, S. Kurosaka, K. Edamura, R. Logothetis, F. DeMayo, P. Troncoso, J. Blando, J. DiGiovanni, and T. Thompson Caveolin-1 upregulation contributes to c-Myc-induced high-grade prostatic intraepithelial neoplasia and prostate cancer Mol. Cancer Res. 10 2012 218 229
236. Z.D. Nassar, H. Moon, T. Duong, L. Neo, M.M. Hill, M. Francois, R.G. Patron, and M.O. Parat PTRF/Cavin-1 decreases prostate cancer angiogenesis and lymphangiogenesis Oncotarget 4 2013 1844 1855
237. S.W. Fine, M.P. Lisanti, F. Galbiati, and M. Li Elevated expression of caveolin-1 in adenocarcinoma of the colon Am. J. Clin. Pathol. 115 2001 719 724
238. F. Sotgia, M.C. Casimiro, G. Bonuccelli, M. Liu, D. Whitaker-Menezes, O. Er, K.M. Daumer, I. Mercier, A.K. Witkiewicz, C. Minetti, F. Capozza, M. Gormley, A.A. Quong, H. Rui, P.G. Frank, J.N. Milliman, E.S. Knudsen, J. Zhou, C. Wang, R.G. Pestell, and M.P. Lisanti Loss of caveolin-3 induces a lactogenic microenvironment that is protective against mammary tumor formation Am. J. Pathol. 174 2009 613 629
239. S.Y. Tong, K.D. Ki, J.M. Lee, M.J. Kang, T.K. Ha, S.I. Chung, S.G. Chi, and S.K. Lee Frequent inactivation of hSRBC in ovarian cancers by promoter CpG island hypermethylation Acta Obstet. Gynecol. Scand. 89 2010 629 635
240. G. Perrone, V. Altomare, M. Zagami, S. Morini, T. Petitti, C. Battista, A. Onetti Muda, and C. Rabitti Caveolin-1 expression in human breast lobular cancer progression Mod. Pathol. 22 2009 71 78
241. L. Shi, Chen Li Wang, L. Zhang, and Z. Chen Expression of caveolin-1 in mucoepidermoid carcinoma of the salivary glands: correlation with vascular endothelial growth factor, microvessel density, and clinical outcome Cancer 109 2007 1523 1531
242. L. Campbell, M. Gumbleton, and D.F. Griffiths Caveolin-1 overexpression predicts poor disease-free survival of patients with clini- cally confined renal cell carcinoma Br. J. Cancer 89 2003 1909 1913
243. P. Zhan, X.K. Shen, Q. Qian, Q. Wang, J.P. Zhu, Y. Zhang, H.Y. Xie, C.H. Xu, K.K. Hao, W. Hu, N. Xia, G.J. Lu, and L.K. Yu Expression of caveolin-1 is correlated with disease stage and survival in lung adenocarcinomas Oncol. Rep. 27 2012 1072 1078
244. D.S. Cho, H. Yim, K.S. Cho, S.J. Hong, N.H. Cho, S.I. Kim, H.S. Ahn, and S.J. Kim Impact of caveolin-1 expression on the prognosis of transitional cell carcinoma of the upper urinary tract J. Korean Med. Sci. 23 2008 296 301
245. J. Xue, H. Chen, L. Diao, X. Chen, and D. Xia Expression of Caveolin-1 in tongue squamous cell carcinoma by quantum dots Eur. J. Histochem. 54 2010 e20
246. C.P. Tanase, S. Dima, M. Mihai, E. Raducan, M.I. Nicolescu, L. Albulescu, B. Voiculescu, T. Dumitrascu, L.M. Cruceru, M. Leabu, I. Popescu, and M.E. Hinescu Caveolin-1 overexpression correlates with tumor progression markers in pancreatic ductal adenocarcinoma J. Mol. Histol. 40 2009 23 29
247. X.X. Wang, Z. Wu, H.F. Huang, C. Han, W. Zou, and J. Liu Caveolin-1, through its ability to negatively regulate TLR4,iscrucial determinant of MAPK activation in LPS-challenged mammary epithelial cells Asian Pac. J. Cancer Prev. 14 2013 2295 2299
248. C. Boscher, and I.R. Nabi Galectin-3 and phosphor-caveolin-1 dependent outside-integrin signaling mediated EGF mitogenic response in mammary cancer cells Mol. Biol. Cell. 24 2013 2134 2145
249. J.H. Lee, M.J. Kang, H.Y. Han, M.G. Lee, S.I. Jeong, B.K. Ryu, T.K. Ha, N.G. Her, J. Han, S.J. Park, K.Y. Lee, H.J. Kim, and S.G. Chi Epigenetic alteration of PRKCDBP in colorectal cancers and its implication in tumor cell resistance to TNF-αinduced apoptosis Clin. Cancer Res. 17 2011 7551 7562
250. T. Shatseva, D.Y. Lee, Z. Deng, and B.B. Yang MicroRNA miR-199a-3p regulates cell proliferation and survival by targeting caveolin-2 J. Cell. Sci. 124 16 2011 2826 2836
251. K.A. Wilson, S.A. Colavito, V. Schulz, P.H. Wakefield, W. Sessa, D. Tuck, and D.F. Stern NFBD1/MDC1 regulates Cav1 and Cav2 independently of DNA damage and p53 Mol. Cancer Res. 9 2011 766 781
252. L.N. Zhao, Z.H. Yang, Y.H. Liu, H.Q. Ying, H. Zhang, and Y.X. Xue Vascular endothelial growth factor increases permeability of the blood-tumor barrier via caveolae-mediated transcellular pathway J. Mol. Neurosci. 44 2011 122 129
253. E. Burgermeister, L. Tencer, and M. Liscovitch Peroxisome proliferator-activated receptor-gamma upregulates caveolin-1 and caveolin-2 expression in human carcinoma cells Oncogene 22 2003 3888 3900
254. F. Capozza, C. Trimmer, R. Castello-Cros, S. Katiyar, D. Whitaker-Menezes, A. Follenzi, M. Crosariol, G. Llaverias, F. Sotgia, R.G. Pestell, and M.P. Lisanti Genetic ablation of Cav1 differentially affects melanoma tumor growth and metastasis in mice: role of Cav1 in Shh heterotypic signaling and transendothelial migration Cancer Res. 72 2012 2262 2274
255. E.J. Kim, J.H. Sohn, M.K. Kim, S.W. Chae, H.S. Lee, E.Y. Cho, and W.H. Kim The loss of expression of caveolin-1 in gastrointestinal stromal tumors Korean J. Pathol. 39 2005 338 344